News

The Alzheimer’s Association will fund UAB projects studying the molecular alterations of inhibitory neurons which take place in patients with Alzheimer's.

Researchers from the IBB-UAB have developed a new class of nanostructures capable of trapping and neutralising large quantities of the SARS-CoV-2 virus particles, both in liquid solutions and on the surface of materials. These novel nanoparticles could be used to manufacture antiviral materials such as wastewater and air filters, and could be exploited to develop new tests for the early detection of COVID-19. Moreover, the nanoparticles could be redesigned to target other pathogens.

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects more than 40 million people. The results were obtained with a single intramuscular administration of the therapeutic viral vectors. The research has also determined that most obese, type 2 diabetic and MASH patients could benefit from the therapy. The results will be the basis for a future clinical trial by the biopharmaceutical company Kriya

As every year, the flu vaccination campaign begins in the fall. As it was done in past seasons, this year it will also be carried out in conjunction with the vaccination against COVID-19.

Wash your hands frequently. Use disposable tissues when coughing or sneezing. Put on the mask covering your nose and mouth. Ventilate closed spaces. Get a flu shot if you're 60 or older, have a chronic illness, or are pregnant.

WHO publishes revised "Laboratory Biosecurity Guidance".

As the weather gets warmer, shorts and sandals become popular choices for outdoor activities. However, when working in a laboratory, it's crucial to wear appropriate attire to minimize the risk of injuries and exposure in the event of an accident.

The registration period for the Postgraduate Course "Strategies in Biosafety and Biocontainment" (13th edition). This course, organized by the Faculties of Biosciences and Veterinary Medicine, has the collaboration of IBC-UAB, IRTA-CReSA and CRAG and is preferably aimed at technicians, lab managers, graduates and professionals in the biomedical, biotechnology, veterinary and agri-food sectors.

15 UAB researcher-driven projects have received funding from the Indústria del Coneixement grant from the Departament de Recerca i Universitats of the Generalitat de Catalunya to improve their value and transfer.

Researchers from four health science departments of the UAB are part of two recently launched partnership projects, promoted by the European Union through the Horizon Europe Programme and the European Defence Fund. On the one hand, EUPAHW, which aims to promote research in animal health and welfare and collaboration with other agents of society from the perspectives of one health and one welfare. On the other hand, RESILIENCE, which will research and develop new medical solutions against potential chemical, biological, radiological and nuclear (CBRN) threats.